These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2264021)

  • 1. Effect of a synthetic thrombin-inhibitor MD805 on the reaction between thrombin and plasma antithrombin-III.
    Hijikata-Okunomiya A; Okamoto S; Wanaka K
    Thromb Res; 1990 Sep; 59(6):967-77. PubMed ID: 2264021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Thrombin.antithrombin III complex].
    Matsuo T; Kario K; Matsuo M
    Rinsho Byori; 1991 Jul; 39(7):701-6. PubMed ID: 1920862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new method for the determination of prothrombin in human plasma.
    Hijikata-Okunomiya A
    Thromb Res; 1990 Mar; 57(5):705-15. PubMed ID: 2339365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of prostanoid formation and regulation of peripheral circulation after surgery using thrombin inhibitor (MD805).
    Onizuka M; Ishikawa S; Ishibashi O; Suga M; Mitsui K; Mitsui T
    Surg Today; 1998; 28(6):618-25. PubMed ID: 9681611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of S-protein of complement with thrombin and antithrombin III during coagulation. Protection of thrombin by S-protein from antithrombin III inactivation.
    Podack ER; Dahlbäck B; Griffin JH
    J Biol Chem; 1986 Jun; 261(16):7387-92. PubMed ID: 3754869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic modulation of thrombin generation associated with human clots by human purified antithrombin alone or in the presence of low molecular weight heparin or unfractionated heparin.
    Meddahi S; Bara L; Fessi H; Samama MM
    Blood Coagul Fibrinolysis; 2000 Jan; 11(1):51-9. PubMed ID: 10691099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interactions between antithrombin III, thrombin and surface immobilized heparin.
    van Delden CJ; Engbers GH; Feijen J
    J Biomater Sci Polym Ed; 1996; 7(11):989-1004. PubMed ID: 8858487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of activated protein C and inactivation of cell-bound thrombin by antithrombin III at the surface of cultured vascular endothelial cells--a comparative study of two anticoagulant mechanisms.
    Delvos U; Meusel P; Preissner KT; Müller-Berghaus G
    Thromb Haemost; 1987 Feb; 57(1):87-91. PubMed ID: 3590084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of thermodynamic nonideality in kinetic studies: evidence of an expanded intermediate complex in the inactivation of thrombin by antithrombin III.
    Hogg PJ; Jackson CM; Winzor DJ
    Biochim Biophys Acta; 1991 Apr; 1073(3):609-13. PubMed ID: 2015284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulant therapy in a congenital antithrombin III (ATIII)-deficient patient with chronic renal failure undergoing regular hemodialysis.
    Matsuo T; Yamada T; Matsuo M; Sakai R
    Biomater Artif Cells Immobilization Biotechnol; 1991; 19(1):185-91. PubMed ID: 1751668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effect of argatroban on thrombin-antithrombin III complex after percutaneous transluminal coronary angioplasty.
    Sakamoto S; Hirase T; Suzuki S; Tsukamoto T; Miki T; Yamada T; Matsuo T
    Thromb Haemost; 1995 Aug; 74(2):801-2. PubMed ID: 8585029
    [No Abstract]   [Full Text] [Related]  

  • 12. Ability of high-affinity heparin fractions with decreasing affinity for antithrombin III to activate ATIII isoforms.
    Carlson TH; Kolman MR; Frees A; Babcock T
    Thromb Res; 1990 Aug; 59(3):521-30. PubMed ID: 2237824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic effect of antithrombin III, activated protein C and heparin on the inhibition of the tissue thromboplastin-mediated coagulation.
    Hirahara K; Etoh Y; Matsuishi T; Suzuki N; Kurata M
    Chem Pharm Bull (Tokyo); 1989 Mar; 37(3):692-6. PubMed ID: 2752479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of heparin activity in plasma by soluble fibrin: evidence for ternary thrombin-fibrin-heparin complex formation.
    Hotchkiss KA; Chesterman CN; Hogg PJ
    Blood; 1994 Jul; 84(2):498-503. PubMed ID: 8025278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of human thrombomodulin on the inactivation of thrombin by human antithrombin III.
    Hirahara K; Koyama M; Matsuishi T; Kurata M
    Thromb Res; 1990 Jan; 57(1):117-26. PubMed ID: 2154059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic selective inhibitors of thrombin.
    Okamoto S; Hijikata-Okunomiya A
    Methods Enzymol; 1993; 222():328-40. PubMed ID: 8412802
    [No Abstract]   [Full Text] [Related]  

  • 17. Antithrombin III: a backward glance o'er travel'd roads.
    Seegers WH
    Adv Exp Med Biol; 1975; 52():195-215. PubMed ID: 47704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerated thrombin generation during anticoagulation in patients with unstable angina pectoris.
    Garabedian HD; Gold HK; Newell JB; Collen D; Hagstrom JN; Bovill EG
    Blood; 1994 Feb; 83(4):1155. PubMed ID: 8111056
    [No Abstract]   [Full Text] [Related]  

  • 19. Abnormalities in thrombin-antithrombin pathway in AL amyloidosis.
    Gamba G; Montani N; Anesi E; Palladini G; Lorenzutti F; Perfetti V; Merlini G
    Amyloid; 1999 Dec; 6(4):273-7. PubMed ID: 10611948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coagulant and noncoagulant thrombin enzymatic activity on the endothelium.
    Frebelius S; Nydahl S; Swedenborg J
    Blood Coagul Fibrinolysis; 1990 Aug; 1(3):285-92. PubMed ID: 2103313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.